MediciNova Gets Positive MS Drug Results
Forbes - NY,USA
Biopharmaceutical company MediciNova Inc. said Tuesday a mid-stage trial of its multiple sclerosis treatment, MN-166, showed a significant increase in the ...
See all stories on this topic

MediciNova Gets Positive MS Drug Results
Houston Chronicle - Houston,TX,USA
SAN DIEGO — Biopharmaceutical company MediciNova Inc. said Tuesday a mid-stage trial of its multiple sclerosis treatment, MN-166, showed a significant ...
See all stories on this topic

MediciNova MS drug successful in phase II testing
Pharmaceutical Business Review - USA
"The divergence of clinical benefit and radiological findings suggest that MN-166 may be acting by a different mode of action than current treatments," said ...
See all stories on this topic

Union: Albertsons flouted law
San Diego Union Tribune - San Diego,CA,USA
San Diego-based MediciNova said a Phase 2 trial of its multiple-sclerosis therapy, MN-166, was successful in increasing the number of patients remaining ...
See all stories on this topic

MediciNova Says Phase II Clinical Trial Of MN- 166 Increases ...
Trading Markets - Los Angeles,CA,USA
(RTTNews) - MediciNova, Inc, (MNOV | charts | news | PowerRating) announced that its Phase II clinical trial of MN-166 intended for treating relapsing ...
See all stories on this topic

MediciNova gets positive MS drug results
Hemscott - London,UK
In addition, data showed patients who did relapse did so significantly later if they took MN-166, rather than the placebo. The two-year study of 297 ...
See all stories on this topic